Leaflet ULTRAVIST 370 768.86mg / ml solution for injection

Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: iopromide (contrast agent)

ATC: V08AB05 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Iopromide is a contrast agent used in medical imaging, particularly in computed tomography (CT) and angiography. It is an iodinated compound that enhances the visualization of internal body structures by increasing the contrast between different tissues.

The medication is administered intravenously or intra-arterially under the supervision of a specialist.

Side effects may include nausea, a warm sensation, allergic reactions, or, in rare cases, kidney dysfunction.

Patients should inform their doctor about any allergies or kidney conditions before administration. Pregnant or breastfeeding women should consult a specialist before use.

General data about ULTRAVIST 370 768.86mg / ml

  • Substance: iopromide
  • Date of latest medicines list: 01-06-2026
  • Product code: W64052001
  • Concentration: 768.86mg / ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 50 ml
  • Product type: Original
  • Price: 99.43 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: BAYER AG - GERMANIA
  • Holder: BAYER AG - GERMANIA
  • Number: 8028/2015/01
  • Shelf life: 3 years

Concentrations available for iopromide

  • 623.40mg/ml
  • 768.86mg/ml